ISCT-compliant MSCs designed for seamless scale-up from research to translational and therapeutic applications.
Advancing cell and gene therapy requires more than access to cells. It demands consistency, scalability, and translational relevance.
At Atlantis Bioscience, we provide cryopreserved human mesenchymal stem cells (hMSCs), including umbilical cord-derived (UC-MSC) and adipose-derived (AD-MSC) sources, designed to support researchers from early discovery through to clinical development. Manufactured under robust and standardised processes in Singapore, these MSCs deliver reliable performance across regenerative medicine, immunomodulation, and extracellular vesicle workflows.
With validated ISCT marker profiles and proven expansion capacity reaching billions of cells within days, this platform empowers laboratories to accelerate research while maintaining confidence in reproducibility and downstream clinical applicability.
Product Features
- Manufactured in Singapore
- Delivers true viable cell yield per vial, not just nominal cell counts
- Rapid expansion to >7 billion cells within 9 days when cultured with STEMGOLD hMSC media
- Available from multiple donors upon request to support experimental flexibility
- Fully compliant with ISCT criteria for MSC identity
- Validated tri-lineage differentiation capability (adipogenic, osteogenic, chondrogenic)



Recommended products
Try the complete hMSC and media system with
- STEMGOLD – hMSC cell culture media
- CryoEase-PF-DMSO containing- hMSC cryopreservation freezing media
- Hypoguard – hMSC transport media